Patient Intake Management

Selected news for the healthcare topic - Patient Intake Management, collected since 10/2017. There are 138 items in the archive. This healthcare topic shares news with Phreesia, Zacks Investment Research, SVB Leerink and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
3/26/2022 Analysts’ Recent Ratings Changes for Phreesia (PHR) - American Banking News American Banking News ... upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $33.00 price target on the stock. According to Zacks, “Phreesia Inc. provides a patient intake management platform. The company’s SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc ...
3/26/2022 Analysts’ Recent Ratings Changes for Phreesia (PHR) com-unik.info ... upgraded by analysts at [Zacks Investment Research] from a “hold” rating to a “buy” rating. They now have a $33.00 price target on the stock. According to Zacks, “Phreesia Inc. provides a patient intake management platform. The company’s SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc ...
3/26/2022 Analysts’ Recent Ratings Changes for Phreesia (PHR) thelincolnianonline.com ... upgraded by analysts at [Zacks Investment Research] from a “hold” rating to a “buy” rating. They now have a $33.00 price target on the stock. According to Zacks, “Phreesia Inc. provides a patient intake management platform. The company’s SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc ...
2/9/2022 Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year mytechdecisions.com RALEIGH, N.C.–(BUSINESS WIRE)–Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care.This is the fourth consecutive year that Phreesia has been ...
2/8/2022 Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year | News | bakersfield.com bakersfield.com RALEIGH, N.C.--(BUSINESS WIRE)--Feb 8, 2022--Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care.This is the fourth consecutive year that Phreesia ...
2/8/2022 Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year | Business Wire Business Wire RALEIGH, N.C.--( BUSINESS WIRE )--Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care.This is the fourth consecutive year that Phreesia has been recognized ...
2/8/2022 Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year phreesia.com Raleigh, N.C., February 8, 2022 – Phreesia is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care.This is the fourth consecutive year that Phreesia has been recognized ...
2/8/2022 Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year Business Wire RALEIGH, N.C.--(BUSINESS WIRE)--Feb 8, 2022--Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care.This is the fourth consecutive year that Phreesia ...
4/8/2021 Phreesia Announces Pricing of Public Offering of Common Stock Yahoo News Phreesia, Inc. ("Phreesia") (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the "Offering") at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares ...
4/8/2021 Phreesia Announces Pricing of Public Offering of Common Stock Yahoo News Phreesia, Inc. ("Phreesia") (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the "Offering") at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares ...
4/8/2021 Phreesia Announces Pricing of Public Offering of Common Stock | Business Wire Business Wire RALEIGH, N.C.--( BUSINESS WIRE )--Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the “Offering”) at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to ...
4/6/2021 Phreesia Announces Proposed Public Offering of Common Stock Yahoo News Phreesia, Inc. ("Phreesia") (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the "Offering"), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The ...
2/2/2021 Phreesia Named 2021 Best in KLAS for Patient Intake Management tmcnet.com Phreesia Named 2021 Best in KLAS for Patient Intake Management [February 02, 2021] Phreesia Named 2021 Best in KLAS for Patient Intake ManagementPhreesia today announced it has been named 2021 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, "2021 Best in KLAS: Software and Services," KLAS recognized the industry's top-performing healthcare IT and services companies, based on feedback ...
2/2/2021 Phreesia Named 2021 Best in KLAS for Patient Intake Management phreesia.com TwitterRaleigh, N.C., February 2, 2021 – Phreesia today announced it has been named 2021 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2021 Best in KLAS: Software and Services,” KLAS recognized the industry’s top-performing healthcare IT and services companies, based on feedback from healthcare organizations.“Each year, thousands of healthcare professionals across the globe take the ...
10/23/2020 Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Business Wire NEW YORK--(BUSINESS WIRE)--Oct 23, 2020--Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,750,000 shares of its common stock (the “Offering”), all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock. The shares were sold at a ...
10/23/2020 Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Business Wire NEW YORK–(BUSINESS WIRE)–Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,750,000 shares of its common stock (the “Offering”), all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock. The shares were sold at a public offering price ...
10/23/2020 Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Business Wire NEW YORK- Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,750,000 shares of its common stock (the “Offering”), all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock. The shares were sold at a public offering price of $32.00 ...
10/21/2020 Phreesia Announces Pricing of Public Offering of Common Stock Business Wire NEW YORK–(BUSINESS WIRE)–Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock (the “Offering”) at a price to the public of $32.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days ...
10/21/2020 Phreesia Announces Pricing of Public Offering of Common Stock | Business & Finance | heraldchronicle.com Business Wire NEW YORK--(BUSINESS WIRE)--Oct 21, 2020--Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock (the “Offering”) at a price to the public of $32.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for ...
10/19/2020 Phreesia Announces Proposed Public Offering of Common Stock Business Wire NEW YORK--(BUSINESS WIRE)--Oct 19, 2020--Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 5,000,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 750,000 additional shares of common stock at the ...